SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950142-03-000921
Filing Date
2003-05-21
Accepted
2003-05-21 16:13:02
Documents
4
Group Members
FRANK H. PEARLGEORGE SOROSPERSEUS BIOTECH FUND PARTNERS, LLCPERSEUS EC, LLCPERSEUS-SOROS BIOPHARMACEUTICAL FUND, LPPERSEUS-SOROS PARTNERS, LLCPERSEUSPUR, LLCSFM AH, LLCSFM PARTICIPATION, LPSOROS FUND MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 sc13ga1-collagenex.txt SC 13G/A 39511
3 EXHIBIT 1 ex1_sc13ga1-collagenex.txt EX-99 5414
4 EXHIBIT 2 ex2_sc13ga1-collagenex.txt EX-24 2569
5 EXHIBIT 3 ex3_sc13ga1-collagenex.txt EX-24 2262
  Complete submission text file 0000950142-03-000921.txt   52508
Mailing Address 888 SEVENTH AVE 33RD FLR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 212-262--6
SOROS GEORGE (Filed by) CIK: 0000900203 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000

Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Subject) CIK: 0001012270 (see all company filings)

IRS No.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47825 | Film No.: 03714685
SIC: 2834 Pharmaceutical Preparations